Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential

Sesamol Attenuates Isoproterenol-induced Acute Myocardial Infarction via Inhibition of Matrix Metalloproteinase-2 and -9 Expression in Rats

(2011) Srinivasan Periasamy et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists

(2011) Parichehr Hassanzadeh et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala

(2011) Lindsey M. Dono et al.   NEUROPHARMACOLOGY

Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity

(2011) Wayne Chadwick et al.   PLoS One

Protective Effect of Sesamol against 3-Nitropropionic Acid-Induced Cognitive Dysfunction and Altered Glutathione Redox Balance in Rats

(2010) Puneet Kumar et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

 2-Adrenoceptor Blockade Accelerates the Neurogenic, Neurotrophic, and Behavioral Effects of Chronic Antidepressant Treatment

(2010) S. U. Yanpallewar et al.   JOURNAL OF NEUROSCIENCE

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat

(2010) R. Abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs

(2010) Parichehr Hassanzadeh et al.   PSYCHOPHARMACOLOGY

Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences

(2010) Baldeep Kumar et al.   PSYCHOPHARMACOLOGY

CB1 Receptor Blockade Decreases Ethanol Intake and Associated Neurochemical Changes in Fawn-Hooded Rats

(2009) Teresa Femenía et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity

(2009) Sung-Wuk Jang et al.   CHEMISTRY & BIOLOGY

Complementary and alternative medicine in the treatment of anxiety and depression

(2009) Gill van der Watt et al.   CURRENT OPINION IN PSYCHIATRY

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

(2009) Francis Rodriguez Bambico et al.   CURRENT PHARMACEUTICAL DESIGN

Altered CB1receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine

(2009) Antonio Rodríguez-Gaztelumendi et al.   JOURNAL OF NEUROCHEMISTRY

NGF Is Essential for Hippocampal Plasticity and Learning

(2009) J. M. Conner et al.   JOURNAL OF NEUROSCIENCE

THE PROTECTIVE EFFECT OF SESAMOL AGAINST MITOCHONDRIAL OXIDATIVE STRESS AND HEPATIC INJURY IN ACETAMINOPHEN-OVERDOSED RATS

(2009) Victor Raj Mohan Chandrasekaran et al.   SHOCK

Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke

(2008) Songming Cheng et al.   NEUROLOGICAL RESEARCH